SIBN

SI-BONE, Inc.

Nasdaq · Surgical & Medical Instruments & Apparatus · Inc. DE · CIK 0001459839
$15.42 +1.85% $683.9M
Insider Selling Cluster (5 insiders)High Impact Filing (7/10)12 New Institutional Positions7 Institutional Exits
Vol
Market Cap$683.9M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (93%)
Inst. Holders50 funds
Inst. Value$226.6M
Inst. Activity12 buys / 7 sells
Insider Activity0B / 12S
Insider Net $-$409.4K
SEC Reports6
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001459839·Prev Close $15.14

Recent Activity

Jun 8, 2026 SEC
SI-BONE's insider cluster shows two directors selling a combined $103.5K in open-market transactions within the same per
CLUSTER — Impact 3/10
Jun 8, 2026 SEC
SI-BONE filed an 8-K covering two routine administrative items: (1) a one-month lease extension for its Santa Clara head
8-K — Impact 2/10
Jun 5, 2026 Insider
DUNN JEFFREY W sold 3,575 shares
Director @ $15.25 ($54.5K)
Jun 4, 2026 other
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
<p align="left">SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN
Jun 4, 2026 Insider
DUNN JEFFREY W was granted 10,957 shares
Director
Jun 4, 2026 Insider
Nishimura Mika was granted 10,957 shares
Director
May 11, 2026 SEC
SI-BONE reported Q1 2026 revenue of $52.6M (+11.2% YoY), beating the $51.2M consensus, and a GAAP net loss of $0.10/shar
8-K — Impact 7/10
Inst.
MORGAN STANLEY — DOUBLED
712,510 shares ($9.0M)

Price Targets

$24.13 +56.5% upside Strong Buy
Current $15.42 Low $18.00 Median $24.00 High $32.00 8 analysts
$18.00 $32.00

Analyst Ratings

Strong Buy93% buy · 15 analysts
4Strong Buy
10Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 12, 2026 TD Cowen MAINTAIN Buy → Buy
May 12, 2026 Truist Securities REITERATE Buy → Buy
Apr 15, 2026 Truist Securities MAINTAIN Buy → Buy
Feb 24, 2026 TD Cowen MAINTAIN Buy → Buy
Feb 24, 2026 Truist Securities REITERATE Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.15 ▲ +3.6% $-0.17 — $-0.13 -10% YoY 7
Next Q $-0.13 ▼ -13.7% $-0.16 — $-0.10 -18% YoY 7
Current FY $-0.43 ▲ +14.3% $-0.50 — $-0.37 3% YoY 7
Next FY $-0.35 ▲ +7.5% $-0.43 — $-0.24 18% YoY 7

Top Institutional Holders

FundValueMove
BlackRock, Inc.$43.3M
VANGUARD CAPITAL MANAGEMENT LLC$22.3M
Nuveen, LLC$16.2M
SILVERCREST ASSET MANAGEMENT GROUP$15.7M
STATE STREET CORP$14.3M

Recent Insider Trades

DateInsiderTypeValue
Jun 5, 2026DUNN JEFFREYSELL$54.5K
Jun 4, 2026DUNN JEFFREYA$0.00
Jun 4, 2026Nishimura MikaA$0.00
Jun 4, 2026Freund JohnA$0.00
Jun 4, 2026West ThomasA$0.00
50 institutional holders with $226.6M total value (17,919,530 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, Nuveen,. Net buying activity: 12 institutions added/increased vs 7 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1BlackRock, Inc.3,428,541$43.3M19.1%
2VANGUARD CAPITAL MANAGEMENT LLC1,764,313$22.3M9.8%
3Nuveen, LLC1,285,511$16.2M7.2%
4SILVERCREST ASSET MANAGEMENT GROUP LLC1,244,584$15.7M6.9%
5STATE STREET CORP1,129,815$14.3M6.3%
6Point72 Asset Management, L.P.840,346$10.6M4.7%ADD +48.6%
7WELLINGTON MANAGEMENT GROUP LLP772,612$9.8M4.3%ADD +74.7%
8MORGAN STANLEY712,510$9.0M4.0%DOUBLED +247.7%
9First Eagle Investment Management, LLC638,941$8.1M3.6%ADD +36.6%
10GOLDMAN SACHS GROUP INC622,442$7.9M3.5%
11DIMENSIONAL FUND ADVISORS LP618,939$7.8M3.4%ADD +41.8%
12RENAISSANCE TECHNOLOGIES LLC472,619$6.0M2.6%DOUBLED +101.6%
13BANK OF AMERICA CORP /DE/419,473$5.3M2.3%ADD +96.1%
14VANGUARD PORTFOLIO MANAGEMENT LLC413,494$5.2M2.3%
15ROYCE & ASSOCIATES LP371,082$4.7M2.1%ADD +25.3%
16CHARLES SCHWAB INVESTMENT MANAGEMENT INC315,471$4.0M1.8%
17SEI INVESTMENTS CO284,769$3.6M1.6%ADD +67.3%
18VANGUARD FIDUCIARY TRUST CO274,691$3.5M1.5%
19Assenagon Asset Management S.A.224,004$2.8M1.2%
20D. E. Shaw & Co., Inc.189,028$2.4M1.1%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
MORGAN STANLEYDOUBLED204,899712,510+247.7%$9.0M2026-Q1
DIMENSIONAL FUND ADVISORS LPADD436,474618,939+41.8%$7.8M2026-Q1
RENAISSANCE TECHNOLOGIES LLCDOUBLED234,400472,619+101.6%$6.0M2026-Q1
ROYCE & ASSOCIATES LPADD296,067371,082+25.3%$4.7M2026-Q1
SEI INVESTMENTS COADD170,187284,769+67.3%$3.6M2026-Q1
MARSHALL WACE, LLPTRIM335,877168,128-49.9%$2.1M2026-Q1
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.ADD104,760138,247+32.0%$1.7M2026-Q1
TUDOR INVESTMENT CORP ET ALTRIM259,589130,116-49.9%$1.6M2026-Q1
Russell Investments Group, Ltd.TRIM183,692122,804-33.1%$1.6M2026-Q1
Universal- Beteiligungs- und Servicegesellschaft mbHTRIM103,07474,229-28.0%$937.5K2026-Q1
CANADA PENSION PLAN INVESTMENT BOARDDOUBLED2,00010,100+405.0%$127.6K2026-Q1
CWM, LLCDOUBLED7694,701+511.3%$59.4K2026-Q1
PNC FINANCIAL SERVICES GROUP, INC.TRIM4,3052,994-30.5%$37.8K2026-Q1
BNP Paribas Asset Management Holding S.A.ADD598861+44.0%$10.9K2026-Q1
Rockefeller Capital Management L.P.DOUBLED70349+398.6%$4.4K2026-Q1
LOS ANGELES CAPITAL MANAGEMENT LLCNEAR_EXIT7,326281-96.2%$3.5K2026-Q1
Allworth Financial LPDOUBLED4134+3250.0%$1.7K2026-Q1
PRICE T ROWE ASSOCIATES INC /MD/ADD37,15949,834+34.1%$630.002026-Q1
HRT FINANCIAL LPTRIM53,55014,868-72.2%$187.002026-Q1
Point72 Asset Management, L.P.ADD502,002745,970+48.6%$14.7M2025-Q4
BANK OF AMERICA CORP /DE/ADD196,774385,785+96.1%$7.6M2025-Q4
MARSHALL WACE, LLPADD192,280335,877+74.7%$6.6M2025-Q4
ROYCE & ASSOCIATES LPADD162,051296,067+82.7%$5.8M2025-Q4
RENAISSANCE TECHNOLOGIES LLCTRIM499,700234,400-53.1%$4.6M2025-Q4
Russell Investments Group, Ltd.ADD133,389183,692+37.7%$3.6M2025-Q4
10 unique insiders with 20 transactions. Net insider value: -$409.4K ($0.00 bought, $409.4K sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 5, 2026DUNN JEFFREY WDirectorSELL3,575$15.25$54.5K
Jun 4, 2026DUNN JEFFREY WDirectorAWARD10,957
Jun 4, 2026Nishimura MikaDirectorAWARD10,957
Jun 4, 2026Freund John GordonDirectorAWARD10,957
Jun 4, 2026West Thomas A.DirectorAWARD10,957
Jun 4, 2026Davis Timothy E JRDirectorAWARD10,957
Jun 4, 2026HILLEMAN JERYL LDirectorAWARD10,957
May 29, 2026Davis Timothy E JRDirectorSELL3,500$14.14$49.5K
May 28, 2026Davis Timothy E JRDirectorEXERCISE12,064$4.32$52.1K
May 28, 2026Davis Timothy E JRDirectorSELL3,780$14.47$54.7K
May 18, 2026Maheshwari AnshulChief Financial OfficerSELL2,477$14.71$36.4K
May 18, 2026FRANCIS LAURAChief Executive OfficerSELL3,893$14.75$57.4K
May 18, 2026PISETSKY MICHAEL A.SVP, Ops & Adm/Chief Legal OfrSELL1,872$14.63$27.4K
May 4, 2026DUNN JEFFREY WDirectorSELL337$13.15$4.4K
Apr 7, 2026Hinckley Greg KDirectorEXERCISE3,085$5.94$18.3K
Apr 2, 2026PISETSKY MICHAEL A.SVP, Ops & Adm/Chief Legal OfrSELL1,301$12.86$16.7K
Apr 2, 2026Maheshwari AnshulChief Financial OfficerSELL1,758$12.92$22.7K
Apr 1, 2026PISETSKY MICHAEL A.SVP, Ops & Adm/Chief Legal OfrSELL1,799$12.95$23.3K
Mar 12, 2026Nishimura MikaDirectorSELL4,100$13.83$56.7K
Feb 2, 2026DUNN JEFFREY WDirectorSELL337$16.42$5.5K

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (93% buy). Based on 15 analysts: 4 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$24.13 mean target +56.5% upside Strong Buy (1.38)
$18.00 Low $32.00 High
MetricValue
Current Price$15.42
Target Low$18.00
Target Mean$24.13
Target Median$24.00
Target High$32.00
# Analysts8
RecommendationStrong Buy (1.38)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.15 $-0.17 $-0.13 -10.2% +3.6% 2↑ 1↓ $0.1B 13.8% 7
Next Q
2026-09-30
$-0.13 $-0.16 $-0.10 -18.2% -13.7% 0↑ 4↓ $0.1B 14.5% 7
Current FY
2026-12-31
$-0.43 $-0.50 $-0.37 2.6% +14.3% 5↑ 0↓ $0.2B 15.3% 7
Next FY
2027-12-31
$-0.35 $-0.43 $-0.24 17.7% +7.5% 3↑ 1↓ $0.3B 15.1% 7

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.154
7d ago$-0.154
30d ago$-0.160+0.006
60d ago$-0.160+0.006
90d ago$-0.161+0.007
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 12, 2026 TD Cowen MAINTAIN Buy Buy
May 12, 2026 Truist Securities REITERATE Buy Buy
Apr 15, 2026 Truist Securities MAINTAIN Buy Buy
Feb 24, 2026 TD Cowen MAINTAIN Buy Buy
Feb 24, 2026 Truist Securities REITERATE Buy Buy
Jan 27, 2026 TD Cowen INITIATE Buy
Dec 18, 2025 Truist Securities MAINTAIN Buy Buy
Dec 17, 2025 Canaccord Genuity MAINTAIN Buy Buy
Dec 16, 2025 Needham MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 202641010093%
May 1, 202641010093%
Apr 1, 202641010093%
Mar 1, 202641110094%
Feb 1, 202641110094%
Jan 1, 202641010093%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 4, 2026
other
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
<p align="left">SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solu
May 13, 2026
short_volume
Short Volume: SIBN — 64.8% short (0.3M / 0.5M)
Short: 326,580 | Exempt: 611 | TRF Vol: 504,039 | Short Ratio: 64.8% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_volume
Short Volume: SIBN — 68.8% short (0.8M / 1.1M)
Short: 775,545 | Exempt: 0 | TRF Vol: 1,126,989 | Short Ratio: 68.8% | Off-exchange volume (dark pool + OTC)
May 11, 2026
earnings
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement in adjusted EBITDA <pre>Delivered ~11% worldwide revenue gr
May 11, 2026
earnings_calendar
SIBN Q1 2026 Earnings Scheduled — 2026-05-11
May 11, 2026
short_volume
Short Volume: SIBN — 66.3% short (0.5M / 0.7M)
Short: 461,837 | Exempt: 0 | TRF Vol: 696,817 | Short Ratio: 66.3% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
other
SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026
<p align="justify">SANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural
Apr 20, 2026
earnings
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
<p>SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to add
Apr 9, 2026
short_volume
Short Volume: SIBN — 88.2% short (0.5M / 0.6M)
Short: 526,643 | Exempt: 0 | TRF Vol: 596,770 | Short Ratio: 88.2% | Off-exchange volume (dark pool + OTC)
Feb 23, 2026
earnings_calendar
SIBN Q4 2025 Earnings After Market Close — 2026-02-23